囊性纤维化的进展

X. Ji, Li Huang, Zhipeng Du, Weijie Li, Fushun Yang
{"title":"囊性纤维化的进展","authors":"X. Ji, Li Huang, Zhipeng Du, Weijie Li, Fushun Yang","doi":"10.3760/CMA.J.ISSN.1673-436X.2020.03.015","DOIUrl":null,"url":null,"abstract":"Cystic fibrosis (CF) is an autosomal recessive hereditary disease with a low incidence in Asia.There are no epidemiological statistics on the incidence of CF in China.CF can lead to dysfunction in multi-system of the whole body.As a safe, fast and easy method, gene detection is becoming more and more important in CF diagnosis.However, the gene mutation spectrum of Chinese population has not yet been proposed.Multidisciplinary combination therapy and gene therapy are the new directions of CF study.At present, there are no guidelines and disease management suitable for the Chinese population.This article reviews the current situation, pathogenesis, clinical manifestations, gene diagnosis and treatment in China. \n \n \nKey words: \nCystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Sweat chloride test; Gene diagnosis","PeriodicalId":10004,"journal":{"name":"Chinese Journal of Asthma","volume":"24 1","pages":"235-237"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Progress of cystic fibrosis\",\"authors\":\"X. Ji, Li Huang, Zhipeng Du, Weijie Li, Fushun Yang\",\"doi\":\"10.3760/CMA.J.ISSN.1673-436X.2020.03.015\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cystic fibrosis (CF) is an autosomal recessive hereditary disease with a low incidence in Asia.There are no epidemiological statistics on the incidence of CF in China.CF can lead to dysfunction in multi-system of the whole body.As a safe, fast and easy method, gene detection is becoming more and more important in CF diagnosis.However, the gene mutation spectrum of Chinese population has not yet been proposed.Multidisciplinary combination therapy and gene therapy are the new directions of CF study.At present, there are no guidelines and disease management suitable for the Chinese population.This article reviews the current situation, pathogenesis, clinical manifestations, gene diagnosis and treatment in China. \\n \\n \\nKey words: \\nCystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Sweat chloride test; Gene diagnosis\",\"PeriodicalId\":10004,\"journal\":{\"name\":\"Chinese Journal of Asthma\",\"volume\":\"24 1\",\"pages\":\"235-237\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-02-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Journal of Asthma\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-436X.2020.03.015\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Asthma","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-436X.2020.03.015","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

囊性纤维化(CF)是一种常染色体隐性遗传病,在亚洲发病率低。中国尚无CF发病率的流行病学统计资料。CF可导致全身多系统功能障碍。基因检测作为一种安全、快速、简便的方法,在CF诊断中越来越重要。然而,中国人群的基因突变谱尚未提出。多学科联合治疗和基因治疗是CF研究的新方向。目前,尚无适合中国人群的指南和疾病管理方法。本文综述了国内的现状、发病机制、临床表现、基因诊断和治疗。关键词:囊性纤维化;囊性纤维化跨膜电导调节剂;汗液氯化物试验;基因诊断
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Progress of cystic fibrosis
Cystic fibrosis (CF) is an autosomal recessive hereditary disease with a low incidence in Asia.There are no epidemiological statistics on the incidence of CF in China.CF can lead to dysfunction in multi-system of the whole body.As a safe, fast and easy method, gene detection is becoming more and more important in CF diagnosis.However, the gene mutation spectrum of Chinese population has not yet been proposed.Multidisciplinary combination therapy and gene therapy are the new directions of CF study.At present, there are no guidelines and disease management suitable for the Chinese population.This article reviews the current situation, pathogenesis, clinical manifestations, gene diagnosis and treatment in China. Key words: Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator; Sweat chloride test; Gene diagnosis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信